
Q32 Bio Inc.
Nasdaq · Pharmaceutical Preparations
Company Overview
A concise company profile alongside the latest public filing activity.
Q32 Bio Inc. is a clinical-stage biotechnology company developing therapies for autoimmune and inflammatory diseases, including conditions affecting the skin and kidneys, by targeting dysregulated immune pathways.
Company profile sourced from SEC filings.
Corporate Insider Trades
Open-market purchases and sales by directors, officers, and other company insiders.
| Insider | Type | Value | Shares / Price | Date |
|---|---|---|---|---|
| Morrison Jodie PopeCEO | Sell | $27K | 3,221at $8.32 | Oct 6, 2026 |
| Kalowski LeeCFO and President | Sell | $11K | 1,301at $8.32 | Oct 6, 2026 |
| Violette Shelia M.Chief Scientific Officer | Sell | $8K | 917at $8.32 | Oct 6, 2026 |
Source: SEC EDGAR Form 4 filings
Congressional Trades
Recent disclosures by members of the U.S. House and Senate.
Source: Senate eFD and House Clerk STOCK Act disclosures
Get notable QTTB activity by email
Free alerts for the insider and congressional trades worth watching.
For informational purposes only, not investment advice. Filings can be delayed, corrected, or amended. Trading activity alone does not predict future performance.